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Diabetic Mothers From the Fetal Through
Late-Infancy StagesClinical and experimental data suggest that maternal
diabetes mellitus (MDM) has transgenerational con-
sequences with a high incidence of cardiovascular
disease (CVD) observed in adult offspring. Infants of
DM mothers (IDMs) are known to evolve ventricular
hypertrophy and diastolic dysfunction in utero.
Although it is assumed these changes resolve post-
natally within months, there are insufficient sup-
portive data. Animal models provide evidence that
MDM may also affect the vascular health of MDM
offspring (1). We performed a longitudinal case-
control study to investigate whether fetal myocar-
dial abnormalities in MDM persist in later infancy,
IDMs demonstrate increased aortic stiffness, and
cardiovascular abnormalities relate to worse maternal
glycemic control.
After informed consent, pregnant mothers with
insulin-dependent pre-gestational diabetes and
healthy controls (no maternal illness, normal glucose
testing) underwent serial fetal echocardiography (at
18 to 24, 26 to 30, and 32 to 36 weeks of gestation),
and their infants underwent postnatal echocardiog-
raphy (at 2 to 6 weeks and 6 to 12 months). We
excluded pregnancies with major fetal abnormalities,
growth restriction (birth weight <10th percentile), or
preterm delivery (#34 weeks). Hemoglobin A1c was
recorded for all 3 trimesters in MDM pregnancies.
Echocardiographic evaluations included assessment
of left ventricular (LV) posterior wall (LVPWd) and
interventricular septal (IVSd) thickness in diastole
and mass, systolic and diastolic function (prenatal
and postnatal), and aortic pulse wave velocity (PWV;
postnatal only).
Thirty-six MDM and 36 control pregnancies were
studied. MDM A1c at each trimester was 7.2  1.1,
6.8  0.9, and 6.6  0.9, respectively. Maternal age,
gravity, parity, body mass index, blood pressures,
delivery method, gestational age, biparietal diameter
and femur length at fetal echo, gestational age at
delivery, infant gender, birth weight and length, and
postnatal weight, length, and age at echo did not
differ between groups.
IDM fetuses demonstrated increased LVPWd and
IVSd thickness compared with controls from latesecond through third trimesters and increased mitral
valve Doppler velocities and LV Tei index in the
third trimester (Table 1). Heart rate and other func-
tion indices did not differ between groups. In early
and late infancy, IDMs demonstrated persistently
increased LVPWd and IVSd (z-scores) and indexed
LV mass. Greater LVPWd and IVSd in late gestation
were associated with greater postnatal LVPWd and
IVSd z-scores (p < 0.001). Of LV function indices,
only LV Tei index was increased in IDMs in late in-
fancy (0.43  0.05 vs. 0.33  0.07; p ¼ 0.05). Aortic
PWV was significantly increased in IDMs in late in-
fancy (3.7  1.2 m/s vs. 2.3  1.0 m/s; p < 0.001) and
correlated with third trimester fetal (R2 ¼ 0.79; p <
0.001 for both) and late infancy (R2 ¼ 0.88 and 0.85,
respectively; p < 0.001) LVPWd and IVSd. Late-
infancy PWV in IDMs demonstrated a strong posi-
tive correlation with third trimester A1c only (R2 ¼
0.84; p < 0.001), whereas LVPWd and IVSd showed
no significant correlations with A1c at any gesta-
tional age.
Our findings suggest increased LV mass persists in
IDMs from mid-gestation through late infancy. IDMs
also demonstrate increased aortic stiffness in late
infancy. That IDM late infancy aortic PWV correlated
with LV wall thickness in late gestation and infancy
could support a causal association or common intra-
uterine insult that could contribute to longer-term
CVD risks.
Maternal hyperglycemia has been suspected to be
responsible for MDM-related fetal cardiomyopathy;
however, this was not supported by our observations.
Increased LV mass in late infancy, long after the in-
trauterine exposure has been removed, suggests
other factors likely contribute. Correlations between
late-gestation A1c and aortic stiffness in late-infancy
IDMs provide further insight into the pathogenesis
of the cardiovascular pathology of IDMs. Hypergly-
cemia in adult diabetes is known to contribute to
inflammation and oxidative stress, which leads to
structural and functional cardiovascular changes
(2,3). Increased inflammatory biomarkers found in
cord blood of MDM pregnancies and altered activity
of genes responsible for vascular development,
integrity, and function (4) may play a role in altered
aortic composition that, in turn, could result in
altered ventricular afterload and changes in LV mass.
Our data suggest the window of fetal vulnerability
may be the third trimester, which could imply that
both gestational and pre-gestational MDM pregnan-
cies are at risk.
TABLE 1 Comparison of Findings in Fetal and Infant IDMs Versus Controls
Control IDM
Birth data
Birth weight 3.39  0.89 3.4  1.2
Birth length 50.2  7.5 50.2  10.2
Gender (F/M) 20/16 17/19
Fetal assessments
First examination (weeks) 20.5  2.3 20.5  2.4
IVSd (cm) 0.20  0.02 0.20  0.02
LVPWd (cm) 0.19  0.01 0.196  0.02
MV e (cm/s) 25.6  6.3 28  6.3
MV a (cm/s) 42.0  7.9 41.9  7.6
MV e/a 0.62  0.09 0.68  0.1
LV Tei index 0.48  0.04 0.46  0.08
MCA PI 1.70  0.31 1.60  0.33
UA PI 1.2  0.25 1.2  0.3
Second examination (weeks) 28.9  1.3 28.8  1.3
IVSd (cm) 0.31  0.03 0.35  0.04†
LVPWd (cm) 0.31  0.03 0.34  0.03†
MV e (cm/s) 36.0  6.9 38.0  9.5
MV a (cm/s) 40.0  8.9 50.0  16
MV e/a ratio 0.91  0.15 0.8  0.16
LV Tei index 0.44  0.12 0.5  0.1
MCA PI 1.65  0.4 1.80  0.3
UA PI 0.97  0.15 1.02  0.2
Third examination (weeks) 34.4  1.3 34.8  1.8
IVSd (cm) 0.35  0.02 0.41  0.04‡
LVPWd (cm) 0.34  0.03 0.39  0.03‡
MV e (cm/s) 43.6  8.8 50.5  7.7†
MV a (cm/s) 54.0  8.0 59.3  8.0*
MV e/a ratio 0.81  0.15 0.86  0.11
LV Tei index 0.33  0.04 0.46  0.07†
MCA PI 1.50  0.2 1.40  0.3
UA PI 0.94  0.17 0.97  0.15
Postnatal assessments
Early infancy (weeks) 4.5  0.8 4.5  1.1
IVS z-score 0.95  0.6 1.9  0.9‡
LVPWd z-score 0.90  0.6 1.8  0.9†
LV mass indexed to BSA 45.8  5.3 54.1  9.2*
Aortic PWV (m/s) 2.3  1.0 2.2  0.8
Late infancy (weeks) 43  2.5 44  2.7
IVS z-score 0.90  0.6 1.8  0.8‡
LVPWd z-score 0.80  0.6 1.7  0.8‡
LV mass indexed to BSA 46.2  4.8 56.5  9.3*
Aortic PWV (m/s) 2.3  1.0 3.7  1.2*
Values are mean  SD. All other functional measures including annular and inflow flow velocities,
E/e’, isovolumic contraction and relaxation times, ejection fraction, and strain and strain rates
(postnatal only) did not differ. Comparisons of continuous variables by unpaired t test. *p < 0.05.
†p < 0.01. ‡p < 0.001.
BSA ¼ body surface area; F ¼ female; IDMs ¼ infants of mothers with diabetes mellitus;
IVSd ¼ interventricular septal; LV ¼ left ventricular; LVPWd ¼ left ventricular posterior wall;
M ¼ male; MV ¼ mitral valve; MCA ¼ middle cerebral artery; PI ¼ pulsatility index ([peak
systolic velocity  end-diastolic velocity]/mean velocity); PWV ¼ pulse wave velocity; UA ¼
umbilical artery.
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Our study was limited by small sample size and
paucity of MDM pregnancies with poor glycemic
control (suggested by A1c values and normal birth
weights), which may have influenced our ability to
demonstrate subtle differences and relationships.
Lack of normative fetal LV wall thickness data pro-
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